Biotech entity
Every one of those 1 sits in a single category, fda-approval. Of the tracked stories, 1 of 1 also mention Pharmaceutical Sector, the most common co-covered peer. We currently track 1 Biotech story that mention Biotech Industry, all published on February 18, 2026.
Last mentioned: Feb 18, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, fda-approval. Of the tracked stories, 1 of 1 also mention Pharmaceutical Sector, the most common co-covered peer. We currently track 1 Biotech story that mention Biotech Industry, all published on February 18, 2026. Each carries 3 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 13 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Biotech Industry. Shared-story counts are live from our verified record — not editorial picks.
The U.S. Food and Drug Administration is moving to eliminate the long-standing requirement for two pivotal clinical trials for new drug approvals. This regulatory shift aims to significantly reduce the time and cost of drug development, prioritizing faster patient access to innovative therapies.
Source: dailybulletin.com · baltimoresun.com
Biotech Industry is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
